Streetbeat News

CBIO

Catalyst Biosciences Inc

CEO

Nassim Usman

Employees

Industry

Pharmaceutical Preparation Manufacturing

catalyst is focused on developing novel medicines to address serious medical conditions for patients who need new or better treatment options. we used a scientific approach focused on protease-based therapeutic candidates to build a clinical-stage biopharmaceutical company whose current mission is to develop valuable therapies for patients with hemophilia. learn more about our hemophilia program. a protease is an enzyme that cleaves target proteins. learn more about proteases.

Open

0.57

Mkt cap

19M

Volume

461K

High

0.58

P/E Ratio

-0.02

52-wk high

8.69

Low

0.48

Div yield

N/A

52-wk low

0.19

Several healthcare stocks experienced significant movement in Monday's after-market session. TransCode Therapeutics, Shuttle Pharmaceuticals, Artelo Biosciences, Catalyst Biosciences, Renalytix, and Vivani Medical saw increases in their share prices, while Orgenesis, GeneDx Hldgs, Catalent, Sientra, Regenxbio, and Akari Therapeutics saw decreases.

Portfolio Pulse from Benzinga Insights

October 30, 2023 | 9:31 pm

Catalyst Biosciences has completed its business combination with GNI Group Ltd. and related entities, and will now operate as Gyre Therapeutics, Inc., trading under the symbol 'GYRE'. The company also implemented a 1-for-15 reverse stock split. Beijing Continent Pharmaceuticals became a majority-owned subsidiary of Gyre as a result of the combination. The changes are effective from October 31, 2023.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2023 | 4:02 pm

The article lists the stocks that gained and lost the most in Wednesday's mid-day session. Among the gainers were Abri SPAC I, Inc., Nuvve Holding Corp., BIO-key International, Inc., and Microsoft Corporation. Among the losers were Appreciate Holdings, Inc., Vicor Corporation, SunPower Corporation, and Alphabet Inc. Owens Corning shares fell by around 9% due to worse-than-expected third-quarter revenue results and issued fourth-quarter net sales guidance.

Portfolio Pulse from Lisa Levin

October 25, 2023 | 5:49 pm

During Wednesday's intraday session, several healthcare stocks experienced significant movements. Werewolf Therapeutics (NASDAQ:HOWL), Reshape Lifesciences (NASDAQ:RSLS), BioXcel Therapeutics (NASDAQ:BTAI), iSpecimen (NASDAQ:ISPC), Titan Pharma (NASDAQ:TTNP), and Catalyst Biosciences (NASDAQ:CBIO) saw their shares rise by 30.0%, 24.06%, 17.94%, 16.66%, 16.5%, and 15.95% respectively. On the other hand, Sonnet BioTherapeutics (NASDAQ:SONN), Motus GI Hldgs (NASDAQ:MOTS), Cibus (NASDAQ:CBUS), DarioHealth (NASDAQ:DRIO), Heart Test Laboratories (NASDAQ:HSCS), and Tharimmune (NASDAQ:THAR) saw their shares decline by 29.6%, 23.65%, 22.94%, 22.34%, 20.63%, and 20.01% respectively.

Portfolio Pulse from Benzinga Insights

October 25, 2023 | 5:31 pm

During Monday's pre-market session, several healthcare stocks experienced significant movements. LumiraDx, INVO Bioscience, Apollomics, TC BioPharm, AcelRx Pharmaceuticals, and SomaLogic saw increases in their share prices, while Revolution Medicines, Mira Pharmaceuticals, Ambrx Biopharma, Catalyst Biosciences, Outlook Therapeutics, and Biocept saw decreases.

Portfolio Pulse from Benzinga Insights

October 23, 2023 | 1:06 pm

The article lists the top gainers and losers in pre-market trading. LumiraDx Limited's shares surged after a strategic collaboration with AstraZeneca and Everton. Akumin Inc. rose after an agreement with Stonepeak to go private. Textainer Group Holdings Limited gained after agreeing to be acquired by Stonepeak. Harpoon Therapeutics, Inc. climbed after disclosing updated interim data from a clinical trial. Roivant Sciences Ltd. rose after Roche agreed to acquire Telavant. Troika Media Group, Inc. fell after reporting financial results. XORTX Therapeutics Inc. dipped after a significant jump on Friday.

Portfolio Pulse from Lisa Levin

October 23, 2023 | 11:32 am

The article lists the stocks that gained and lost the most in Friday's mid-day session. Among the gainers were XORTX Therapeutics, Lipella Pharmaceuticals, and Catalyst Biosciences, while the losers included WEBUY GLOBAL, SolarEdge Technologies, and Processa Pharmaceuticals. Factors influencing these movements include FDA clearances, strategic appointments, acquisitions, and financial results.

Portfolio Pulse from Lisa Levin

October 20, 2023 | 5:45 pm

Several healthcare stocks experienced significant price movements during Friday's intraday session. Notable gainers included Aravive, Lipella Pharmaceuticals, Sagimet Biosciences, Catalyst Biosciences, Redhill Biopharma, and Eiger BioPharmaceuticals. On the other hand, Processa Pharma, Atreca, RVL Pharmaceuticals, Adial Pharmaceuticals, Renovaro Biosciences, and Outlook Therapeutics saw their stock prices decline.

Portfolio Pulse from Benzinga Insights

October 20, 2023 | 5:31 pm

The article reports on the significant stock movements in Monday's mid-day session. Notable gainers include MingZhu Logistics Holdings Limited, PCTEL, Inc., and Almacenes Éxito S.A., while Streamline Health Solutions, Inc., Aldeyra Therapeutics, Inc., and Biocept, Inc. were among the biggest losers. The article also mentions several other companies whose stocks experienced significant changes.

Portfolio Pulse from Lisa Levin

October 16, 2023 | 5:09 pm

During Friday's intraday session, several healthcare stocks experienced significant movements. Bio-Path Hldgs, Processa Pharma, Harpoon Therapeutics, SELLAS Life Sciences Gr, Agape ATP, and Assure Hldgs saw their stocks rise, with Bio-Path Hldgs leading the gainers with a 60.6% increase. On the other hand, Bellerophon Therapeutics, Outset Medical, Harmony Biosciences, Comera Life Sciences, Catalyst Biosciences, and PMV Pharma saw their stocks decline, with Bellerophon Therapeutics leading the losers with a 64.9% decrease.

Portfolio Pulse from Benzinga Insights

October 13, 2023 | 5:31 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.